Ph.D. Valeska Schroeder - 08 Jun 2023 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Reporting relationship: Director
Issuer ticker: SGHT
Reported as of: 08 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jun 2023, 17:59:43 UTC
Prior SEC filing: 05 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Jeremy Hayden, Attorney-in-Fact for Valeska Schroeder, Ph.D.

Filing notes and source

Key filing fact

Ph.D. Valeska Schroeder filed Form 4 for Sight Sciences, Inc. (SGHT) on 12 Jun 2023.

Key facts

This page summarizes Ph.D. Valeska Schroeder's Form 4 filing for Sight Sciences, Inc. (SGHT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2023, 17:59.

Change

Previous filing in this sequence was filed on 05 Aug 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGHT transaction

Common Stock

Award

Transaction value: $0
Shares: +11,940
Change %
Price: $0.000000
Shares after: 11,940
Date: 08 Jun 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on June 8, 2022 under the Issuer's Non-Employee Director Compensation Program, as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on August 5, 2022. Each RSU represented a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share. The RSUs vested in full on June 8, 2023.